Cancer Research UK funded a record £315m of research last year. The milestone marks nearly a doubling in research funding since the Charity was formed five years ago, according to its annual report and accounts published today (Friday 14 September 2007).
Before Terry died, he knew that an annual event would be held to commemorate his Marathon of Hope. It would be called, appropriately, The Terry Fox Run.
Every three minutes a man finds out he has prostate cancer — the second-leading cause of cancer death in American men. In fact, more than 218,890 cases are expected in 2007, making prostate cancer among men more prevalent than breast cancer among women.
University of Iowa researchers have discovered a gene that plays a linchpin role in the ability of breast cancer cells to respond to estrogen. The finding may lead to improved therapies for hormone-responsive breast cancers, and may explain differences in the effectiveness of current treatments.
The U.S. Food and Drug Administration approved Evista (raloxifene hydrochloride) for reducing the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer.
Cephalon, Inc. (Nasdaq: CEPH) communicated with healthcare professionals to clarify the appropriate patient selection, dosing and administration for FENTORA(R) (fentanyl buccal tablet) [C-II].
Variations in a gene that influences the innate immune system?the part of the immune system that provides short-term protection against infection?may be associated with lung cancer survival.
Having at least some education beyond high school is associated with a decreased risk of dying from cancer among black and white men and women, according to a study published online September 11 in the Journal of the National Cancer Institute.
An increase in high-grade prostate cancer among men taking the drug finasteride is likely caused by an increased detection of cancers, and not by the development of more high-grade cancers, according to two studies published online September 11 in the Journal of the National Cancer Institute.
Research here shows that an obscure form of RNA, part of the protein-making machinery in all cells, might play an important role in human cancer. These ultraconserved non-coding RNAs (UCRs) have been considered ?junk? by some researchers, but a new report in the September issue of the journal Cancer Cell indicates that this may not be the case.